Erythema News and Research

RSS
FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

First lots of 2013-2014 seasonal influenza vaccine released for U.S. distribution

Clinical trial finds that sleep quality impacts skin function and aging

Clinical trial finds that sleep quality impacts skin function and aging

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

FDA approves Novartis' Exelon Patch for treatment of severe Alzheimer's disease

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

New study to discover preventive use of antibiotics for Lyme disease

New study to discover preventive use of antibiotics for Lyme disease

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting